EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice

Sandra Gabriela Klein, Kelem Cristina Pereira Mota, Bruna Cristina Borges, Mylla Spirandelli Vieira, Matheus Morais Neves, Ludmilla Silva Mendes, Flávia Batista Ferreira, Isabela Lemos de Lima iD, Fabiana de Almeida Araújo Santos iD, Luciana Machado Bastos, Wânia Rezende Lima, Luiz Ricardo Goulart Filho iD und 1 weitere

International Journal of Molecular Sciences · 24.03.2026 · 27 (7) · 2950

DOI: 10.3390/ijms27072950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2026. Verfasst von Sandra Gabriela Klein und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Laboratory in Experimental Models-LABME, Federal University of Uberlândia, Uberlândia 38402-018, MG, Brazil. Hauptthemen laut MEDLINE: Malaria, Cerebral, Single-Chain Antibodies, Plasmodium berghei, Glycosylphosphatidylinositols. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Rede Mineira de Biotecnologia em Modelos Experimentais (RMBME), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria remains a major global health challenge. While treatments targeting parasite replication exist, effective interventions for neurological manifestations are scarce, necessitating new strategies for cerebral malaria. In this study, we investigated the effect of a single-chain variable fragment (scFv) against glycosylphosphatidylinositol (GPI) as an intervention tool to mitigate the effects of Plasmodium in a preclinical model. We used C57BL/6J mice infected with Plasmodium berghei-ANKA (PbA) and treated them with anti-GPI scFv or phosphate-buffered saline (PBS) on days 0, 3, and 6 post-infection. Uninfected controls were treated on the same days with scFv or PBS. The animals were evaluated for morbidity and mortality, body weight, parasitemia, blood count, cytokines, and histopathology. Results show that anti-GPI scFv prevented lethality in 71.4% of infected animals and promoted recovery from weight loss. Furthermore, the intervention inhibited neurological and systemic signs, reduced parasitemia, and improved hematological and histopathological parameters in the brain, lungs, and kidneys. In conclusion, anti-GPI scFv exerts a significant systemic effect on experimental cerebral malaria (ECM) pathology, representing a promising tool for severe manifestations of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria, CerebralSingle-Chain AntibodiesPlasmodium bergheiGlycosylphosphatidylinositolsAnimalsMiceParasitemiaMice, Inbred C57BLDisease Models, AnimalBrainFemaleCytokines

Stichwörter der Autor:innen

Plasmodium berghei ANKAexperimental cerebral malariaglycosylphosphatidylinositolnanobiotechnologysingle-chain variable fragment

Substanzen

Single-Chain AntibodiesGlycosylphosphatidylinositolsCytokines

Autor:innen und Institutionen

  • Biotechnology Laboratory in Experimental Models-LABME, Federal University of Uberlândia, Uberlândia 38402-018, MG, Brazil.
  • Laboratory of Nanobiotechnology (NANOs), Federal University of Uberlândia, Uberlândia 38402-018, MG, Brazil.
  • Institute of Biotechnology, Federal University of Catalão, Catalão 75706-881, GO, Brazil.

ORCID-Profile: Isabela Lemos de Lima, Fabiana de Almeida Araújo Santos, Luiz Ricardo Goulart Filho

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Rede Mineira de Biotecnologia em Modelos Experimentais (RMBME)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Ministério Público do Trabalho de Uberlândia (MPT)
  • Universidade Federal de Uberlândia (UFU)
  • National Institute of Science and Technology in Theranostics and Nanobiotechnology - INCT-Teranano, Brazil
  • National Institute of Science and Technology in Theranostics and Nanobiotechnology—INCT-Teranano

Zitieren

APA

Klein, S. G., Mota, K. C. P., Borges, B. C., Vieira, M. S., Neves, M. M., Mendes, L. S., Ferreira, F. B., de Lima, I. L., Santos, F. A. A., Bastos, L. M., Lima, W. R., Goulart Filho, L. R., & Vieira da Silva, M. (2026). Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice. International Journal of Molecular Sciences, 27(7), 2950. https://doi.org/10.3390/ijms27072950

Vancouver

Klein SG, Mota KCP, Borges BC, Vieira MS, Neves MM, Mendes LS, et al. Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice. International Journal of Molecular Sciences. 2026;27(7):2950. doi:10.3390/ijms27072950

BibTeX
@article{Klein2026,
  author = {Klein, Sandra Gabriela and Mota, Kelem Cristina Pereira and Borges, Bruna Cristina and Vieira, Mylla Spirandelli and Neves, Matheus Morais and Mendes, Ludmilla Silva and Ferreira, Flávia Batista and de Lima, Isabela Lemos and Santos, Fabiana de Almeida Araújo and Bastos, Luciana Machado and Lima, Wânia Rezende and Goulart Filho, Luiz Ricardo and Vieira da Silva, Murilo},
  title = {Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2950},
  doi = {10.3390/ijms27072950}
}
Kostenlos starten →